Results
9
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
9 companies
AprilBioLtd
Market Cap: ₩691.7b
AprilBio Co., Ltd. develops long-acting type biobetter and antibody biologics.
A397030
₩30,650.00
7D
14.6%
1Y
42.9%
PharmaResearch
Market Cap: ₩5.7t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩550,000.00
7D
0.5%
1Y
185.6%
Oscotec
Market Cap: ₩1.7t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩45,400.00
7D
2.3%
1Y
33.7%
ALTEOGEN
Market Cap: ₩25.2t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩471,500.00
7D
3.6%
1Y
40.3%
Macrogen
Market Cap: ₩167.9b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩15,490.00
7D
-0.8%
1Y
-10.7%
3billion
Market Cap: ₩237.6b
Develops technology for rare disease drug discovery using bioinformatics and machine learning technology.
A394800
₩7,490.00
7D
-6.1%
1Y
n/a
Seegene
Market Cap: ₩1.2t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩25,200.00
7D
-0.6%
1Y
5.2%
Medy-Tox
Market Cap: ₩847.2b
Operates as a biopharmaceutical company in South Korea.
A086900
₩120,700.00
7D
-2.1%
1Y
-34.9%
ABL Bio
Market Cap: ₩5.3t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩95,400.00
7D
2.3%
1Y
204.8%